ALS Trial Raises Questions About Promising Drug

  title={ALS Trial Raises Questions About Promising Drug},
  author={J. Couzin},
  pages={1227 - 1227}
  • J. Couzin
  • Published 2007
  • Medicine
  • Science
  • CLINICAL RESEARCH![Figure][1] Bombshell. Patients on therapy declined more rapidly than those on a placebo. An antibiotic long thought to hold promise for treating neurologic diseases failed dramatically in a recent clinical trial; this news has sparked a debate about why the drug 
    13 Citations

    Topics from this paper.

    Immunity to self and self-maintenance: what can tumor immunology teach us about ALS and Alzheimer's disease?
    • 22
    • PDF
    Aberrant Neuregulin 1 Signaling in Amyotrophic Lateral Sclerosis
    • 43
    • PDF
    The executioners sing a new song: killer caspases activate microglia
    • 37
    • PDF
    Minocycline for axonal regeneration after nerve injury: A double-edged sword
    • 11